| Literature DB >> 29911317 |
Mylène de Ruijter1,2, Alexandre Ribeiro1,2, Inge Dokter1,2, Miguel Castilho1,2,3, Jos Malda1,2,4.
Abstract
Fabrication of biomimetic tissues holds much promise for the regeneration of cells or organs that are lost or damaged due to injury or disease. To enable the generation of complex, multicellular tissues on demand, the ability to design and incorporate different materials and cell types needs to be improved. Two techniques are combined: extrusion-based bioprinting, which enables printing of cell-encapsulated hydrogels; and melt electrowriting (MEW), which enables fabrication of aligned (sub)-micrometer fibers into a single-step biofabrication process. Composite structures generated by infusion of MEW fiber structures with hydrogels have resulted in mechanically and biologically competent constructs; however, their preparation involves a two-step fabrication procedure that limits freedom of design of microfiber architectures and the use of multiple materials and cell types. How convergence of MEW and extrusion-based bioprinting allows fabrication of mechanically stable constructs with the spatial distributions of different cell types without compromising cell viability and chondrogenic differentiation of mesenchymal stromal cells is demonstrated for the first time. Moreover, this converged printing approach improves freedom of design of the MEW fibers, enabling 3D fiber deposition. This is an important step toward biofabrication of voluminous and complex hierarchical structures that can better resemble the characteristics of functional biological tissues.Entities:
Keywords: biofabrication; complex tissue architectures; convergence; melt electrowriting; reinforcement
Mesh:
Substances:
Year: 2018 PMID: 29911317 PMCID: PMC7116487 DOI: 10.1002/adhm.201800418
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933
Figure 1Convergence of MEW (PCL) and extrusion-based bioprinting (gelMA) into a single-step approach A) allows for control over spatial placement of cells. Control over positioning of cells (membrane-labeled eMSCs) while using MEW and extrusion-based bioprinting B) (top view) results in hierarchical structures C) (top view), and the ability to fabricate porous constructs while including MEW D) (top view) and layered distribution in z-direction E) (cross section; arrow indicates where MEW mesh was positioned). eMSCs stained with DiI (red), DiO (blue/yellow), and DiD (green). Scale bars = 400 μm.
Figure 2Toward more complex tissue architectures: using hydrogel (Pluronics, 40% w/v) to guide the direction of MEW (PCL) fibers. MEW fibers are guided over a single strand of hydrogel A), interlocked with hydrogel B). This enables more complex fiber architectures C) and out-of-plane fiber deposition D). Yellow arrows depict the hydrogel whereas the white arrows depict the PCL fiber. Scale bar = 500 μm.
Figure 3Convergence in a single-step approach does not affect the reinforcing effect of the MEW fibers. An increase in the compressive peak A) and equilibrium B) modulus was found when combining MEW (PCL) printing and extrusion-based hydrogel printing (10% gelMA). No differences were found between the converged printed and the cast samples. * = p < 0.05.
Figure 4Effect of environmental conditions on cells. Converged printing increases printing time of constructs, which is related to the volume and line spacing of the prints A). Converged printed constructs with a volume of 100 mm3 and a line spacing of 400 μm, resulted in 10 min of printing time per construct. Incubating the hydrogel after crosslinking decreased metabolic activity of the cells B). Metabolic activity was normalized against cast control sample without incubation time. * = significant difference from an incubation time of 0 min, p < 0.05.
Figure 5MSC behavior after converged printing process. Cell viability (t = 14 d) in converged printing (CP) approach was comparable to cast control sample for all voltages used A). Chondrogenic differentiation was not compromised by the converged printing (CP) approach, showing no statistical differences in GAG/DNA compared with cast samples, for 5, 10, and 15 kV B). Safranin-O and collagen type II staining shows good proteoglycan and collagen type II distribution throughout the entire construct C). Scale bar = 100 μm, * = p < 0.05.